Boeing Company (The) (BA)

Key Updates

Boeing shares advanced 2.62% to $228.89 since the May 27 report, extending the recovery from the May 21 pullback and reaching the highest level in the current reporting cycle. The rally was supported by CEO Kelly Ortberg's confirmation that 737 production has increased to 47 jets monthly with FAA approval, up from the previous 42-unit rate, while Bangladesh finalized its 14-aircraft order announced in late April. The stock has now gained 5.42% year-to-date despite a modest 0.79% decline over the past month, with the 6-month performance of 21.11% reflecting the broader production recovery narrative. The potential China order of approximately 500 aircraft remains in focus following President Trump's China Summit, though no formal announcement has materialized in the current reporting period.

Current Trend

Boeing has established a clear uptrend over the past six months with a 21.11% gain, though the year-to-date performance of 5.42% indicates the majority of gains occurred in late 2025. The stock has demonstrated resilience above the $220 psychological level, which served as support during the May 21 decline to $217.78 and has now been surpassed with the current price at $228.89. Short-term momentum remains positive with gains of 2.05% over one day, 3.01% over five days, and 2.62% since the last report, though the one-month decline of 0.79% suggests some consolidation following the earlier rally. The stock is testing resistance in the $228-$230 range, with the next significant level likely near the recent cycle highs.

Investment Thesis

The investment thesis centers on Boeing's operational recovery through production rate increases and market share recapture in key geographies. The company's ability to scale 737 production from 38 jets monthly (the FAA-imposed cap following the January 2024 panel blowout) to the current 47 units, with plans to reach 52 monthly by early 2025 through a fourth Everett production line, demonstrates regulatory approval and manufacturing capability restoration. The potential China order of 500 aircraft would reverse a seven-year sales freeze dating to March 2019 and could add five MAX deliveries monthly, representing significant revenue visibility against the 6,100-plane backlog. The Bangladesh order and South Asia's projected widebody fleet tripling over 20 years provide additional geographic diversification beyond traditional Western markets. However, the thesis faces constraints from supplier bottlenecks limiting near-term delivery acceleration and the company's cumulative losses exceeding $35 billion from 2019 to 2024, despite the $2.2 billion profit achieved in 2023.

Thesis Status

The thesis is strengthening with tangible execution progress. The production rate increase to 47 monthly units represents a 23.7% improvement from the previous 38-unit cap and positions Boeing ahead of the early 2025 target of 52 units, validating management's operational turnaround strategy. The formalization of the Bangladesh order, while modest at 14 aircraft, confirms Boeing's ability to compete against Airbus in emerging markets where trade considerations favor U.S. manufacturers. The 787 program returning to eight monthly units with plans to reach ten later this year demonstrates widebody production stabilization alongside narrowbody recovery. However, the China order remains unconfirmed despite CEO Ortberg's participation in the Trump China Summit, introducing execution risk to the most significant near-term catalyst. The company's ability to convert the 6,100-plane backlog into cash flow remains constrained by supplier capacity, tempering the immediate financial impact of new orders.

Key Drivers

The primary catalyst is the 737 production increase to 47 jets monthly following FAA consultation, with plans to reach 52 units in early 2025 through a fourth Everett production line. This removes the 38-unit monthly cap imposed after the January 2024 panel blowout incident and provides a clear path to margin improvement through fixed cost absorption. The Biman Bangladesh Airlines order for 14 Boeing aircraft, comprising 787 Dreamliners and 737 MAX jets, demonstrates competitive positioning in South Asia where the widebody fleet is projected to triple over 20 years. The potential China order of approximately 500 aircraft would represent Boeing's first Chinese purchase since 2017 and could add five MAX deliveries monthly, though the deal remains unconfirmed despite CEO participation in the Trump China Summit. The 787 program returning to eight monthly units with plans to reach ten later this year provides widebody production stability, while ongoing certification efforts for the 737 MAX 7 and 10 variants offer additional revenue streams once approved.

Technical Analysis

Boeing is trading at $228.89, representing a 2.62% gain since the May 27 report and establishing a higher high above the $223.04 level. The stock has maintained support above $220 following the May 21 test at $217.78, confirming this psychological level as a near-term floor. The five-day gain of 3.01% and one-day advance of 2.05% indicate strengthening momentum, though the one-month decline of 0.79% suggests the stock is working through resistance in the $225-$230 range. The year-to-date performance of 5.42% lags the six-month gain of 21.11%, indicating the majority of the rally occurred in the fourth quarter of 2025. The current price action suggests a test of the upper end of the recent trading range, with a breakout above $230 potentially targeting the next resistance zone. Volume and momentum indicators would need confirmation to sustain moves beyond current levels, particularly given the consolidation pattern over the past month.

Bull Case

• 737 production rate increased to 47 jets monthly with FAA approval, representing 23.7% improvement from the 38-unit cap and providing a clear path to 52 monthly units in early 2025 through the fourth Everett production line, which will drive significant margin expansion through fixed cost leverage and accelerate backlog conversion of 6,100 aircraft.
• Potential China order of approximately 500 aircraft would reverse a seven-year sales freeze since March 2019 and could add five MAX deliveries monthly, representing substantial revenue visibility at approximately $100 million list price per aircraft (discounted in practice) and validating Boeing's competitive position in the world's largest aviation market.
• South Asia widebody fleet projected to triple over 20 years, with the Bangladesh order of 14 aircraft demonstrating Boeing's ability to capture emerging market growth where the 787-10 offers the lowest cost per seat among widebody aircraft and delivers 20-25% fuel-use improvement compared to replaced aircraft.
• 787 production returned to eight units monthly with plans to reach ten later this year, indicating widebody program stabilization alongside narrowbody recovery and providing diversified revenue streams across both market segments with ongoing certification efforts for 737 MAX 7 and 10 variants offering additional growth opportunities.
• Trade considerations favor U.S. manufacturers in emerging markets, as demonstrated by Bangladesh's shift from Airbus to Boeing to address a $6 billion trade imbalance with the United States and mitigate potential tariff increases on its export-dependent garment industry, creating competitive advantages beyond pure aircraft economics.

Bear Case

• Production constraints from existing 6,100-plane backlog and supplier bottlenecks limit near-term delivery acceleration despite new orders, meaning major deliveries from any China order would not occur until 2028, delaying cash flow benefits and constraining the company's ability to capitalize on demand momentum in the near term.
• Cumulative losses exceeding $35 billion from 2019 to 2024 reflect sustained operational and financial challenges, with the 2023 profit of $2.2 billion partly attributable to the $10.6 billion Jeppesen subsidiary sale rather than core operations, raising questions about sustainable profitability at current production rates.
• China order remains unconfirmed despite CEO participation in Trump China Summit, introducing execution risk to the most significant near-term catalyst, with China having maintained the longest MAX grounding of any nation (since March 2019) suggesting potential political or regulatory obstacles to order finalization and delivery acceptance.
• January 2024 panel blowout incident led to FAA production cap, demonstrating ongoing quality control challenges that required regulatory intervention and could recur if production acceleration compromises manufacturing standards, potentially triggering additional caps or delivery delays that would undermine the recovery thesis.
• Bangladesh order represents only 14 aircraft, a modest addition to the 6,100-plane backlog that provides limited financial impact relative to the company's scale, while the reliance on trade considerations rather than pure product competitiveness suggests vulnerability to shifting geopolitical dynamics or Airbus competitive responses in emerging markets.